Time to change the way we think about tuberculosis infection prevention and control in health facilities: insights from recent research
暂无分享,去创建一个
F. Bozzani | N. McCreesh | C. Colvin | H. MacGregor | T. Yates | K. Kielmann | A. Karat | A. Grant | Peter G. Beckwith | I. Govender
[1] Richard G. White,et al. Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods , 2023, BMJ Global Health.
[2] F. Cobelens,et al. Disease Transmission by Patients With Subclinical Tuberculosis , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] D. Dowdy,et al. Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications , 2022, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Deol,et al. Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South Africa , 2022, PLOS global public health.
[5] A. Vassall,et al. Estimating waiting times, patient flow, and waiting room occupancy density as part of tuberculosis infection prevention and control research in South African primary health care clinics , 2022, PLOS global public health.
[6] T. Greenhalgh,et al. Health worker experiences of implementing TB infection prevention and control: A qualitative evidence synthesis to inform implementation recommendations , 2022, PLOS global public health.
[7] Richard G. White,et al. Estimating the contribution of subclinical tuberculosis disease to transmission: An individual patient data analysis from prevalence surveys , 2022, medRxiv.
[8] James Campbell,et al. Urgent need to invest in health and care workers , 2022, The Lancet.
[9] J. Oeltmann,et al. Tuberculosis attributed to transmission within healthcare facilities, Botswana—The Kopanyo Study , 2022, Infection Control & Hospital Epidemiology.
[10] N. Ford,et al. Evaluation of HIV treatment outcomes with reduced frequency of clinical encounters and antiretroviral treatment refills: A systematic review and meta-analysis , 2022, PLoS medicine.
[11] F. Cobelens,et al. How “Subclinical” is Subclinical Tuberculosis? An Analysis of National Prevalence Survey Data from Zambia , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] A. Vassall,et al. Using system dynamics modelling to estimate the costs of relaxing health system constraints: a case study of tuberculosis prevention and control interventions in South Africa , 2021, Health Policy and Planning.
[13] T. Ndung’u,et al. Prevalence of Mycobacterium tuberculosis in Sputum and Reported Symptoms Among Clinic Attendees Compared With a Community Survey in Rural South Africa , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] C. Ku,et al. Durations of asymptomatic, symptomatic, and care-seeking phases of tuberculosis disease with a Bayesian analysis of prevalence survey and notification data , 2021, BMC Medicine.
[15] C. Colvin,et al. Organisational Culture and Mask-Wearing Practices for Tuberculosis Infection Prevention and Control among Health Care Workers in Primary Care Facilities in the Western Cape, South Africa: A Qualitative Study , 2021, International journal of environmental research and public health.
[16] R. Chaisson,et al. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis , 2021, The Lancet. Infectious diseases.
[17] C. Fraser,et al. Rates of viral suppression in a cohort of people with stable HIV from two community models of ART delivery versus facility-based HIV care in Lusaka, Zambia: a cluster-randomised, non-inferiority trial nested in the HPTN 071 (PopART) trial , 2021, The lancet. HIV.
[18] Richard G. White,et al. Estimating the contribution of transmission in primary healthcare clinics to community-wide TB disease incidence, and the impact of infection prevention and control interventions, in KwaZulu-Natal, South Africa , 2021, BMJ Global Health.
[19] Richard G. White,et al. Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa , 2021, BMJ Global Health.
[20] R. White,et al. Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens , 2021, PloS one.
[21] A. Grant,et al. Health system influences on the implementation of tuberculosis infection prevention and control at health facilities in low-income and middle-income countries: a scoping review , 2021, BMJ Global Health.
[22] D. Dowdy,et al. Infection status of contacts is not associated with severity of TB in the index case. , 2021, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[23] A. Chughtai,et al. Context matters: Examining the factors impacting the implementation of tuberculosis infection prevention and control guidelines in health settings in seven high tuberculosis burden countries. , 2021, Journal of infection and public health.
[24] B. Allegranzi,et al. Implementation of the infection prevention and control core components at the national level: a global situational analysis , 2020, The Journal of hospital infection.
[25] A. Grant,et al. ‘It has become everybody’s business and nobody’s business’: Policy actor perspectives on the implementation of TB infection prevention and control (IPC) policies in South African public sector primary care health facilities , 2020, Global public health.
[26] A. Grant,et al. Barriers and facilitators of tuberculosis infection prevention and control in low- and middle-income countries from the perspective of healthcare workers: A systematic review , 2020, PloS one.
[27] G. Gartlehner,et al. [WHO Guidelines on Tuberculosis Infection Prevention and Control]. , 2020, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).
[28] A. Odone,et al. Subclinical Tuberculosis Disease—A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening Methodology , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] J. Seeley,et al. Tuberculosis infection prevention and control: why we need a whole systems approach , 2020, Infectious Diseases of Poverty.
[30] R. Wood,et al. Aerosolization of Mycobacterium tuberculosis by Tidal Breathing , 2020, bioRxiv.
[31] Nicholas Stacey,et al. Estimating a cost-effectiveness threshold for health care decision-making in South Africa , 2020, Health policy and planning.
[32] E. Nardell,et al. Cool but dangerous: How climate change is increasing the risk of airborne infections. , 2020, Indoor air.
[33] S. Birring,et al. Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies , 2020, The Lancet. Infectious diseases.
[34] B. Allegranzi,et al. Creation of a national infection prevention and control programme in Sierra Leone, 2015 , 2019, BMJ Global Health.
[35] D. Dowdy,et al. Screening for tuberculosis: time to move beyond symptoms. , 2019, The Lancet. Respiratory medicine.
[36] A. R. Escombe,et al. Improving natural ventilation in hospital waiting and consulting rooms to reduce nosocomial tuberculosis transmission risk in a low resource setting , 2019, BMC Infectious Diseases.
[37] A. Crampin,et al. Risk of Mycobacterium tuberculosis transmission in an antiretroviral therapy clinic , 2018, AIDS.
[38] V. Zweigenthal,et al. Assessing the impact of a waiting time survey on reducing waiting times in urban primary care clinics in Cape Town, South Africa , 2017, Journal of public health in Africa.
[39] F. Tanser,et al. Measuring ventilation and modelling M. tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[40] P. Sonnenberg,et al. Bioaerosol production by patients with tuberculosis during normal tidal breathing: implications for transmission risk , 2016, Thorax.
[41] Richard G. White,et al. The transmission of Mycobacterium tuberculosis in high burden settings. , 2016, The Lancet. Infectious diseases.
[42] M. Pagano,et al. Institutional Tuberculosis Transmission. Controlled Trial of Upper Room Ultraviolet Air Disinfection: A Basis for New Dosing Guidelines. , 2015, American journal of respiratory and critical care medicine.
[43] E. Nardell,et al. F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[44] T. Cohen,et al. High Rates of Potentially Infectious Tuberculosis and Multidrug-Resistant Tuberculosis (MDR-TB) among Hospital Inpatients in KwaZulu Natal, South Africa Indicate Risk of Nosocomial Transmission , 2014, PloS one.
[45] Leslie London,et al. Wind-Driven Roof Turbines: A Novel Way to Improve Ventilation for TB Infection Control in Health Facilities , 2012, PloS one.
[46] A. R. Escombe,et al. Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission , 2009, PLoS medicine.
[47] Richard L Vincent,et al. Safety of Upper-Room Ultraviolet Germicidal Air Disinfection for Room Occupants: Results from the Tuberculosis Ultraviolet Shelter Study , 2008, Public health reports.
[48] A. R. Escombe,et al. Natural Ventilation for the Prevention of Airborne Contagion , 2007, PLoS medicine.
[49] D. Milton,et al. Risk of indoor airborne infection transmission estimated from carbon dioxide concentration. , 2003, Indoor air.
[50] K. Schwartzman,et al. Measuring ventilation of patient care areas in hospitals. Description of a new protocol. , 1995, American journal of respiratory and critical care medicine.
[51] L. Moulton,et al. A Cluster Randomized Trial of Systematic Targeted Universal Testing for Tuberculosis in Primary Care Clinics of South Africa (The TUTT Study) , 2022, SSRN Electronic Journal.
[52] J. Seeley,et al. Beyond checklists: Using clinic ethnography to assess the enabling environment for tuberculosis infection prevention control in South Africa. , 2022, PLOS Global Public Health.
[53] OUP accepted manuscript , 2021, Clinical Infectious Diseases.